CBS issued an Amber Phase Advisory (2019-05-08) due to an unprecedented increase in SCIg utilization and imminent shortage of Cuvitru brand SCIg in Canada.

As a result, a working group consisting of neurologists, hematologists, immunologists and patient advocates issued short-term management recommendations to mitigate the risk to patients and their access to SCIg. Learn More.

TMAG has endorsed a statement for physicians to use when obtaining Informed Consent for the use of Plasma Protein Products. The statement primarily addresses infectious disease risk, and may be utilized as a memo or aide for physicians who prescribe PPP's for their patients. Learn more

Two new Standardized Provincial Procedures developed by TRG are now available on the TraQ website - learn more

See more news...

• IVIG Dose Calculator
• TBI
• IVIG Infusion Rate Table
• BC Recommendations
• TraQ